World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
7114
World Ranking
4551
National Ranking
2050

Jeffrey K. Actor publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jeffrey K. Actor sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 185 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jeffrey K. Actor D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey K. Actor sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jeffrey K. Actor is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research spans multiple fields with a focus on Medicine, Immunology and Microbiology, and Nursing. Subfields of their studies include Immunology, Nutrition and Dietetics, Infectious Diseases, Epidemiology, and Surgery.

Their recent research contributions include the following notable papers:

  • The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm, 2021, International Immunopharmacology
  • GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?, 2020, Frontiers in Immunology
  • Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection, 2020, Frontiers in Cellular and Infection Microbiology
  • New insights into the systemic effects of oral lactoferrin: transcriptome profiling, 2020, Biochemistry and Cell Biology
  • Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease, 2021, npj Vaccines

Frequent areas of research topics covered by Jeffrey K. Actor include:

  • Infant Nutrition and Health
  • Tuberculosis Research and Epidemiology
  • Neonatal Respiratory Health Research
  • Immunodeficiency and Autoimmune Disorders
  • Immune Response and Inflammation
  • Immune Cell Function and Interaction
  • Urticaria and Related Conditions

Their collaborative work involves frequent co-authors such as Marian L. Kruzel, Shen-An Hwang, Thao Nguyen, Zainab Niaz, and Robert L. Hunter, reflecting active research partnerships.

Jeffrey K. Actor's studies are prominently published in venues including Biochemistry and Cell Biology, International Immunopharmacology, Frontiers in Immunology, Frontiers in Cellular and Infection Microbiology, and npj Vaccines.

Best Publications

  • Lactoferrin as a Natural Immune Modulator

    Jeffrey K. Actor;Shen-An Hwang;Marian L. Kruzel

  • Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.

    J. K. Actor;M. Shirai;M. C. Kullberg;R. M. L. Buller

  • Lactoferrin in a Context of Inflammation-Induced Pathology.

    Marian L Kruzel;Michal Zimecki;Jeffrey K Actor

  • Cord factor trehalose 6,6'-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages.

    Jessica Indrigo;Robert L. Hunter;Jeffrey K. Actor

  • Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease.

    Robert L. Hunter;Margaret R. Olsen;Chinnaswamy Jagannath;Jeffrey K. Actor

  • Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs.

    Robert L. Hunter;Chinnaswamy Jagannath;Jeffrey K. Actor

  • Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice

    M. L. Kruzel;Y. Harari;D. Mailman;J. K. Actor

  • Trehalose 6,6′-Dimycolate and Lipid in the Pathogenesis of Caseating Granulomas of Tuberculosis in Mice

    Robert L. Hunter;Margaret Olsen;Chinnaswamy Jagannath;Jeffrey K. Actor

  • Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages

    Jessica Indrigo;Robert L. Hunter;Jeffrey K. Actor

  • INDUCTION OF NITRIC OXIDE IN HUMAN MONOCYTES AND MONOCYTE CELL LINES BY MYCOBACTERIUM TUBERCULOSIS

    Chinnaswamy Jagannath;Jeffrey K Actor;Robert Lee Hunter

  • A Humanized Mouse Model of Tuberculosis

    Veronica E. Calderon;Gustavo Valbuena;Yenny Goez;Barbara M. Judy

  • Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.

    Xin Xing Tan;Jeffrey K Actor;Yin Chen

  • Terrestrial stress analogs for spaceflight associated immune system dysregulation.

    Brian Crucian;Richard J. Simpson;Satish Mehta;Raymond Stowe

  • Cytokine profile suggesting that murine cerebral malaria is an encephalitis.

    V. M. Jennings;Jeffrey K Actor;A. A. Lal;Robert L Hunter

  • Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6'-dimycolate.

    Rafael L. Perez;Jesse Roman;Susanne Roser;Candice Little

  • Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium.

    Sara M. Dann;Heuy Ching Wang;Kimberly J. Gambarin;Jeffrey K. Actor

  • A role for tumour necrosis factor-α, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6′-dimycolate induced granulomatous response

    Kerry J. Welsh;April N. Abbott;Shen An Hwang;Jessica Indrigo

  • Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response

    Byung-Kwon Choi;Jeffrey K. Actor;Sandra Rios;Marc d’Anjou

  • Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA.

    Suresh R Pai;Jeffrey K Actor;Eliud Sepulveda;Robert L Hunter

  • Pathogenesis of Post Primary Tuberculosis: Immunity and Hypersensitivity in the Development of Cavities

    Robert L. Hunter;Jeffrey K. Actor;Shen An Hwang;Vadim Karev

  • Lactoferrin immunomodulation of DTH response in mice

    Jeffrey K. Actor;Shen An Hwang;Margaret Olsen;Michal Zimecki

  • Lactoferrin in health and disease.

    Marian L. Kruzel;Jeffrey K. Actor;Istvan Boldogh;Michael Zimecki

Frequent Co-Authors

Robert L. Hunter
Robert L. Hunter The University of Texas Health Science Center at Houston
Rick A. Wetsel
Rick A. Wetsel The University of Texas Health Science Center at Houston
Dorothy E. Lewis
Dorothy E. Lewis The University of Texas Health Science Center at Houston
Alan Sher
Alan Sher National Institute of Allergy and Infectious Diseases
Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Istvan Boldogh
Istvan Boldogh The University of Texas Medical Branch at Galveston
A. Clinton White
A. Clinton White The University of Texas Medical Branch at Galveston
Michael R. Blackburn
Michael R. Blackburn The University of Texas Health Science Center at Houston
Pablo C. Okhuysen
Pablo C. Okhuysen The University of Texas MD Anderson Cancer Center
Edward A. Graviss
Edward A. Graviss Houston Methodist

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open many career doors. Many professionals start with accelerated programs to quickly build foundational skills. For example, accelerated FNP programs provide a faster route to becoming a Family Nurse Practitioner, combining clinical practice with advanced knowledge.

Similarly, if you don’t have a nursing background but want to enter the field swiftly, consider 12-month accelerated nursing programs online for non nurses. These programs welcome students from diverse academic pathways, helping them transition into nursing and immunology-related roles efficiently.

Continuing education is also crucial for specialization. For example, nurses looking to deepen their expertise in critical care can explore the fnp to acute care certification, which facilitates a smooth transition into acute care nurse practitioner roles.

Lastly, if you prefer programs with easier admission processes to quickly start your career, look into 12-month accelerated nursing programs. These programs are designed to provide quality education in a condensed timeline, helping students enter the workforce faster.

Best Scientists Citing Jeffrey K. Actor

Trending Scientists

Recently Published Articles